In the last three months, 19 analysts have published ratings on Ecolab ECL, offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 8 | 10 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 3 | 2 | 0 | 0 |
| 2M Ago | 0 | 4 | 7 | 0 | 0 |
| 3M Ago | 0 | 1 | 1 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $238.21, a high estimate of $260.00, and a low estimate of $216.00. This upward trend is evident, with the current average reflecting a 11.31% increase from the previous average price target of $214.00.
Diving into Analyst Ratings: An In-Depth Exploration
A clear picture of Ecolab's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Roberts | Mizuho | Raises | Buy | $260.00 | $216.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $256.00 | $237.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $238.00 | - |
| Pavel Molchanov | Raymond James | Raises | Outperform | $250.00 | $230.00 |
| Charles Neivert | Piper Sandler | Announces | Overweight | $260.00 | - |
| Vincent Andrews | Morgan Stanley | Raises | Equal-Weight | $240.00 | $230.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $238.00 | - |
| Manav Patnaik | Barclays | Raises | Overweight | $260.00 | $225.00 |
| Seth Weber | Wells Fargo | Raises | Overweight | $250.00 | $240.00 |
| Andrew Wittmann | Baird | Raises | Neutral | $232.00 | $184.00 |
| John McNulty | BMO Capital | Raises | Market Perform | $227.00 | $212.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $237.00 | $220.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $238.00 | - |
| John Roberts | Mizuho | Raises | Neutral | $216.00 | $210.00 |
| Manav Patnaik | Barclays | Raises | Equal-Weight | $225.00 | $215.00 |
| Shlomo Rosenbaum | Stifel | Raises | Hold | $225.00 | $193.00 |
| Jeffrey Zekaukas | JP Morgan | Raises | Neutral | $220.00 | $200.00 |
| Ashish Sabadra | RBC Capital | Raises | Outperform | $238.00 | $213.00 |
| Steve Byrne | B of A Securities | Raises | Neutral | $216.00 | $185.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ecolab. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ecolab compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Ecolab's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Ecolab's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Ecolab analyst ratings.
About Ecolab
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the U.S. market and is growing its presence abroad.
Financial Insights: Ecolab
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Positive Revenue Trend: Examining Ecolab's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.28% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Net Margin: Ecolab's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.29% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Ecolab's ROE stands out, surpassing industry averages. With an impressive ROE of 5.12%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Ecolab's ROA excels beyond industry benchmarks, reaching 1.85%. This signifies efficient management of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 1.09, Ecolab faces challenges in effectively managing its debt levels, indicating potential financial strain.
The Significance of Analyst Ratings Explained
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
